Ann: ITL Launches more Blood Sector Products, page-4

This is my opinion.

A year ago there was strong sales growth through SKM, this turned out to be seasonal/un-sustained.

Growth forecasts are currently not super impressive and management sold into the share buy back, which does nothing for confidence.

The business is largely back to pinning it success on MHT.

If and when ITD kicks some goals. We will then see the benefit of the buy back...

I sold half my stock into the buy back when I heard management were getting on board. So effectively free hold my current holding, will now play the long game unless a reason to sell presents itself